俄亥俄州 的 肺癌 临床试验
俄亥俄州 有 67 项针对 肺癌 的研究正在招募参与者。
俄亥俄州 的城市
- Columbus36 项研究
- Cleveland26 项研究
- Cincinnati19 项研究
- Akron16 项研究
- Dayton14 项研究
- Toledo11 项研究
- Parma5 项研究
- Zanesville5 项研究
- Chillicothe5 项研究
- Newark5 项研究
- Youngstown4 项研究
- Mansfield3 项研究
- Marion3 项研究
官方研究文本（英文）
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- University of Cincinnati Cancer Center, Cincinnati
- The Ohio State University, Columbus
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月30日 · NCT06765109Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Cleveland Clinic Akron General, Akron
- Strecker Cancer Center-Belpre, Belpre
- Aultman Health Foundation, Canton
- 以及另外 33 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月30日 · NCT04267848Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
- UH Seidman Cancer Center at UH Avon Health Center, Avon
- UHHS-Chagrin Highlands Medical Center, Beachwood
- Strecker Cancer Center-Belpre, Belpre
- 以及另外 21 项
招募中3 期
70 岁及以上 · 所有性别 · 更新于 2026年9月30日 · NCT06096844Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- UH Seidman Cancer Center at UH Avon Health Center, Avon
- UHHS-Chagrin Highlands Medical Center, Beachwood
- Strecker Cancer Center-Belpre, Belpre
- 以及另外 28 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月29日 · NCT04181060Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
- TriHealth Cancer & Blood Institute Research, Cincinnati
- Taylor Cancer Research Center, Maumee
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月29日 · NCT06881784Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Aultman Health Foundation, Canton
- Miami Valley Hospital South, Centerville
- Ohio State University Comprehensive Cancer Center, Columbus
- 以及另外 4 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月29日 · NCT06498635A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
- GSK Investigational Site, Canton
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT07099898Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Aultman Hospital, Canton
- Aultman Medical Group Hematology and Oncology, Canton
- Oncology Hematology Care Clinical Trials, Cincinnati
- 以及另外 7 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT07222566This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- University Hospitals Seidman Cancer Center at UH Avon Health Center, Avon
- University Hospitals Cleveland Medical Center, Cleveland
- University Hospitals Seidman Cancer Center at UH Mentor Health Center, Mentor
- 以及另外 1 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06758401A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Dayton Physician's Network, Dayton
招募中3 期
18 至 100 岁 · 所有性别 · 更新于 2026年9月25日 · NCT05920356Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- Research Site, Cleveland
招募中2 期
18 至 95 岁 · 所有性别 · 更新于 2026年9月23日 · NCT05061550A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
- Cleveland Clinic, Cleveland
- Local Institution - 0102, Columbus
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月23日 · NCT06618287A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
招募中2/3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月23日 · NCT07063745A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)
- GSK Investigational Site, Canton
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月23日 · NCT07602855Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
- University Hospitals Cleveland Medical Center, Cleveland
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C, Columbus
招募中2/3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT07100080Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- Gabrail Cancer Center Research, Canton
- The Christ Hospital Cancer Center, Cincinnati
- University of Cincinnati Medical Center, Cincinnati
- 以及另外 5 项
招募中2/3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT06712316Pulmonary Rehabilitation in Advanced Lung Cancer Survivors
- University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT07104630Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- Case Western Reserve University, Cleveland
- Ohio State University Comprehensive Cancer Center, Columbus
- 以及另外 1 项
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月17日 · NCT06287775A Study Evaluating a New Radiation Treatment Workflow (NGDS)
- University Hospital Cleveland Medical Center, Cleveland
招募中
21 岁及以上 · 所有性别 · 更新于 2026年9月17日 · NCT07824583Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Cleveland Clinic, Cleveland
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月16日 · NCT05786924The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- The Cleveland Clinic Taussig Cancer Center, Cleveland
招募中1/2 期
12 岁及以上 · 所有性别 · 更新于 2026年9月15日 · NCT04585750Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer
- Ohio State University Comprehensive Cancer Center, Columbus
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月15日 · NCT04780568A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Ohio State University, Columbus
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月8日 · NCT06793215A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Miami Valley Hospital South, Centerville
- USO - Oncology Hematology Care, Cincinnati
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月8日 · NCT06119581A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
- Ohio State University Hospital, Columbus
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月8日 · NCT06561685Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
- Case Western Reserve University, Cleveland
- Ohio State University Comprehensive Cancer Center, Columbus
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月4日 · NCT07012031A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- The Ohio State University (OSU) Wexner Medical Center, Columbus
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月4日 · NCT06400472Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
- Cleveland Clinic, Cleveland
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月3日 · NCT06343402The Vanguard Study: Testing a New Way to Screen for Cancer
- Louis Stokes Cleveland VA Medical Center, Cleveland
招募中欢迎健康志愿者
45 至 75 岁 · 所有性别 · 更新于 2026年9月2日 · NCT06995898Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Summa Health System - Akron Campus, Akron
- Cleveland Clinic Akron General, Akron
- Summa Health System - Barberton Campus, Barberton
- 以及另外 44 项
招募中观察性研究欢迎健康志愿者
40 至 75 岁 · 所有性别 · 更新于 2026年9月2日 · NCT05334069Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
- Ohio State University Hospitals, Columbus
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月1日 · NCT07185997Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Cleveland Clinic - Akron General Hematology & Oncology, Akron
- Cleveland Clinic Mercy Hospital Cancer Center, Canton
- The Christ Hospital Cancer Center, Cincinnati
- 以及另外 5 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月1日 · NCT06712355Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- Cleveland Clinic Akron General, Akron
- UH Seidman Cancer Center at UH Avon Health Center, Avon
- UHHS-Chagrin Highlands Medical Center, Beachwood
- 以及另外 20 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年8月17日 · NCT05624996Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- Ohio State University Comprehensive Cancer Center, Columbus
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年8月17日 · NCT06500481A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- The Ohio State University Comprehensive Cancer Center, Columbus
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年8月11日 · NCT05592626Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
- University Hospital - Cleveland Medical Center, Cleveland
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年8月5日 · NCT07444814Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Xencor Investigative Site, Cincinnati
- Xencor Investigative Site, Columbus
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年8月3日 · NCT05433142Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
- Dayton VA Medical Center, Dayton
招募中
50 至 80 岁 · 所有性别 · 更新于 2026年7月16日 · NCT07168993Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy
- Ohio State University Comprehensive Cancer Center, Columbus
招募中欢迎健康志愿者
60 岁及以上 · 所有性别 · 更新于 2026年7月8日 · NCT06139627Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- University Hospitals Cleveland Medical Center, Cleveland
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年6月30日 · NCT06162221数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。